Therapeutic immunization for HIV. (Q36619422)

15 August 2017

1 reference

title

Therapeutic immunization for HIV. (English)

1 reference

15 August 2017

author

Lindvi Gudmundsdotter

1

object named as

Lindvi Gudmundsdotter

1 reference

15 August 2017

8

Britta Wahren

1 reference

15 August 2017

Anna Sjödin

2

1 reference

15 August 2017

Ann-Charlotte Boström

3

1 reference

15 August 2017

Bo Hejdeman

4

1 reference

15 August 2017

Rebecca Theve-Palm

5

1 reference

15 August 2017

Annette Alaeus

6

1 reference

15 August 2017

Knut Lidman

7

1 reference

15 August 2017

publication date

10 October 2006

1 reference

Seminars in Immunopathology

15 August 2017

published in

1 reference

15 August 2017

volume

28

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

221-230

1 reference

Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00281-006-0029-0

Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00281-006-0029-0

DNA vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00281-006-0029-0

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00281-006-0029-0

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00281-006-0029-0

Immunological responses to envelope glycoprotein 120 from subtypes of human immunodeficiency virus type 1.

21 January 2018

1 reference

12 December 2020

A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8 T-cell immune response

1 reference

12 December 2020

Gradual adaptation of HIV to human host populations: good or bad news?

1 reference

12 December 2020

Cross-clade T cell recognition of HIV.1.

1 reference

12 December 2020

A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research

1 reference

12 December 2020

Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".

1 reference

12 December 2020

A Toll-like receptor recognizes bacterial DNA

1 reference

12 December 2020

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

12 December 2020

Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.

1 reference

12 December 2020

The molecular clock of HIV-1 unveiled through analysis of a known transmission history

1 reference

12 December 2020

DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy

1 reference

12 December 2020

Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

12 December 2020

A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection

1 reference

12 December 2020

The rationale behind a vaccine based on multiple HIV antigens

1 reference

12 December 2020

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

1 reference

12 December 2020

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

12 December 2020

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

1 reference

12 December 2020

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

1 reference

12 December 2020

Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).

1 reference

12 December 2020

HIV regulatory and accessory proteins: new targets for vaccine development

1 reference

12 December 2020

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

12 December 2020

DNA mucosal HIV vaccine in humans

1 reference

12 December 2020

Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys

1 reference

12 December 2020

DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses

1 reference

12 December 2020

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

1 reference

12 December 2020

Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial. Nordic VAC-04 Study Group

1 reference

12 December 2020

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

1 reference

12 December 2020

Biological features of genetic immunization

1 reference

12 December 2020

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

1 reference

12 December 2020

Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens

1 reference

12 December 2020

Vaccination with Rev and Tat against AIDS.

1 reference

12 December 2020

Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays

1 reference

12 December 2020

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

1 reference

12 December 2020

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

1 reference

12 December 2020

Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization

1 reference

12 December 2020

Horizontal transfer of DNA by the uptake of apoptotic bodies

1 reference

12 December 2020

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

12 December 2020

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

1 reference

12 December 2020

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

1 reference

12 December 2020

Control of viral rebound through therapeutic immunization with DermaVir

1 reference

12 December 2020

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

12 December 2020

Gene gun transfection of animal cells and genetic immunization

1 reference

12 December 2020

A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques

1 reference

12 December 2020

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

1 reference

12 December 2020

HIV-specific immunity during structured antiviral drug treatment interruption

1 reference

12 December 2020

Cellular HIV-1 immune responses in natural infection and after genetic immunization.

1 reference

12 December 2020

Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up

1 reference

12 December 2020

Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes

1 reference

12 December 2020

Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.

1 reference

12 December 2020

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

1 reference

12 December 2020

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

12 December 2020

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

12 December 2020

Therapeutic dendritic-cell vaccine for simian AIDS.

1 reference

12 December 2020

10.1007/S00281-006-0029-0

Identifiers

DOI

1 reference

15 August 2017

1 reference